+

WO2008152398A3 - Formulations for inhalation - Google Patents

Formulations for inhalation Download PDF

Info

Publication number
WO2008152398A3
WO2008152398A3 PCT/GB2008/002029 GB2008002029W WO2008152398A3 WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3 GB 2008002029 W GB2008002029 W GB 2008002029W WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhalation
formulations
propellant
polymer
optionally
Prior art date
Application number
PCT/GB2008/002029
Other languages
French (fr)
Other versions
WO2008152398A2 (en
Inventor
Arnar Lulla
Geena Malhotra
Original Assignee
Cipla Limited
Curtis, Philip, Anthony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Limited, Curtis, Philip, Anthony filed Critical Cipla Limited
Publication of WO2008152398A2 publication Critical patent/WO2008152398A2/en
Publication of WO2008152398A3 publication Critical patent/WO2008152398A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical aerosol formulation comprising an active material coated with a polymer, in combination with a propellant, optionally with other pharmaceutically acceptable excipients.
PCT/GB2008/002029 2007-06-14 2008-06-12 Formulations for inhalation WO2008152398A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1123MU2007 2007-06-14
IN1123/MUM/2007 2007-06-14
IN1249/MUM/2007 2007-06-29
IN1249MU2007 2007-06-29
IN1253/MUM/2007 2007-07-02
IN1253MU2007 2007-07-02

Publications (2)

Publication Number Publication Date
WO2008152398A2 WO2008152398A2 (en) 2008-12-18
WO2008152398A3 true WO2008152398A3 (en) 2009-11-12

Family

ID=39869725

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/002029 WO2008152398A2 (en) 2007-06-14 2008-06-12 Formulations for inhalation

Country Status (1)

Country Link
WO (1) WO2008152398A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
TR201007251A2 (en) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Calcium channel blocker formulation.
CN103874483B (en) 2011-10-11 2017-09-12 奇斯药制品公司 It has been coated the crystal fine particle of the beta-agonists of aliphatic acid
EP2877178A1 (en) 2012-07-26 2015-06-03 Wockhardt Limited Pharmaceutical composition comprising diamorphine for intranasal administration
MX2015003731A (en) * 2012-10-23 2015-06-15 Cipla Ltd Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane.
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
CN106551909A (en) * 2015-09-23 2017-04-05 苏州欧米尼医药有限公司 A kind of preparation method of high dispersive fine powder granule
CN110840864B (en) * 2019-12-20 2022-02-22 广州健康元呼吸药物工程技术有限公司 Beta 2 receptor agonist inhalation aerosol and product containing same
CN117122564B (en) * 2023-09-26 2024-05-14 海南卓科制药有限公司 Fluorouracil injection and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034596A2 (en) * 1997-02-07 1998-08-13 Minnesota Mining And Manufacturing Company Biocompatible compounds for pharmaceutical drug delivery systems
WO1999038493A1 (en) * 1998-01-30 1999-08-05 Rtp Pharma Inc. Microparticle inhalation formulations
WO2002003958A1 (en) * 2000-07-11 2002-01-17 Astrazeneca Ab Novel aerosol formulation containing a polar fluorinated molecule
WO2003063843A1 (en) * 2002-02-01 2003-08-07 Astrazeneca Ab Composition for inhalation
US6641800B1 (en) * 1991-09-25 2003-11-04 Fisons Ltd. Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
WO2005055985A1 (en) * 2003-12-10 2005-06-23 Medpharm Limited Metered dose inhalation preparations of therapeutic drugs
WO2005056037A1 (en) * 2003-12-10 2005-06-23 Medpharm Limited Metered dose inhalation preparations of proteins and peptides

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641800B1 (en) * 1991-09-25 2003-11-04 Fisons Ltd. Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
WO1998034596A2 (en) * 1997-02-07 1998-08-13 Minnesota Mining And Manufacturing Company Biocompatible compounds for pharmaceutical drug delivery systems
WO1999038493A1 (en) * 1998-01-30 1999-08-05 Rtp Pharma Inc. Microparticle inhalation formulations
WO2002003958A1 (en) * 2000-07-11 2002-01-17 Astrazeneca Ab Novel aerosol formulation containing a polar fluorinated molecule
WO2003063843A1 (en) * 2002-02-01 2003-08-07 Astrazeneca Ab Composition for inhalation
WO2005055985A1 (en) * 2003-12-10 2005-06-23 Medpharm Limited Metered dose inhalation preparations of therapeutic drugs
WO2005056037A1 (en) * 2003-12-10 2005-06-23 Medpharm Limited Metered dose inhalation preparations of proteins and peptides

Also Published As

Publication number Publication date
WO2008152398A2 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2008152398A3 (en) Formulations for inhalation
WO2008120207A3 (en) Compositions for nasal delivery
WO2006101882A3 (en) Medicament delivery formulations, devices and methods
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2007121318A3 (en) Formulations for delivering insulin
WO2008109462A3 (en) Sustained release pellets comprising wax-like material
WO2009062746A3 (en) Topical drugs for use in antifungal therapy
WO2010006143A3 (en) Transdermal estrogen device and delivery
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
WO2009061607A3 (en) Water-immiscible materials as vehicles for drug delivery
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
WO2006131931A3 (en) Patch for transdermal drug delivery
EP2109483A4 (en) Aerosol delivery mask
WO2010052466A8 (en) Pharmaceutical aerosol composition
EP1998751A4 (en) Devices, systems and methods for medicament delivery
HK1101346A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
WO2008145348A3 (en) Dispensing device
WO2009043049A3 (en) Pharmaceutical formulations
NZ612326A (en) Biodegradable drug delivery compositions
WO2012002640A3 (en) Transdermal drug delivery system containing donepezil
WO2010027405A3 (en) Formulations of gc-c receptor agonist polypeptides
MX2013000642A (en) Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators.
WO2010027404A3 (en) Stable formulation comprising therapeutic polypeptides for oral administration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08762359

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2342/MUMNP/2009

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 08762359

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载